MENU
+Compare
RCKT
Stock ticker: NASDAQ
AS OF
Dec 1 closing price
Price
$3.16
Change
-$0.26 (-7.60%)
Capitalization
341.98M

RCKT Rocket Pharmaceuticals Forecast, Technical & Fundamental Analysis

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company... Show more

Industry: #Biotechnology
RCKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RCKT with price predictions
Dec 01, 2025

RCKT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 04, 2025

RCKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 39 cases where RCKT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RCKT's RSI Indicator exited the oversold zone, of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on RCKT as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RCKT just turned positive on November 26, 2025. Looking at past instances where RCKT's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RCKT advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

RCKT moved below its 50-day moving average on December 01, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RCKT crossed bearishly below the 50-day moving average on November 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCKT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RCKT entered a downward trend on December 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.090) is normal, around the industry mean (27.247). P/E Ratio (0.000) is within average values for comparable stocks, (52.214). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.890). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (320.114).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RCKT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
RCKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RCKT is expected to report earnings to fall 4.82% to -42 cents per share on March 02

Rocket Pharmaceuticals RCKT Stock Earnings Reports
Q4'25
Est.
$-0.43
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.10
The last earnings report on November 06 showed earnings per share of -44 cents, beating the estimate of -49 cents. With 2.75M shares outstanding, the current market capitalization sits at 341.98M.
A.I. Advisor
published General Information

General Information

a provider of gene therapy services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9 Cedarbrook Drive
Phone
+1 609 659-8001
Employees
268
Web
https://www.rocketpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCEHY79.810.77
+0.97%
Tencent Holding Ltd.
HYSR0.03N/A
+0.31%
SunHydrogen Inc.
ILPMY4.18N/A
N/A
Permanent TSB Group Holdings plc
BKKLY25.21-0.34
-1.33%
Bangkok Bank Public Co Ltd.
BTRMF0.09-0.02
-20.11%
Battery Mineral Resources Corp.

RCKT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-7.60%
SVRA - RCKT
59%
Loosely correlated
-7.23%
PRTA - RCKT
53%
Loosely correlated
-4.37%
AXON - RCKT
52%
Loosely correlated
-1.28%
VCYT - RCKT
47%
Loosely correlated
-2.01%
RGNX - RCKT
43%
Loosely correlated
-5.83%
More